The ‘entourage effect’ or ‘hodge-podge hashish’: the questionable rebranding, marketing, and expectations of cannabis polypharmacy

From a 2020 article in Expert Review of Clinical Pharmacology ( https://www.tandfonline.com/toc/ierj20/current ) author Peter Cogan penned an opinion piece and literature review of the broad definition of the entourage effect, a brief summary of cannabis polypharmacy, and a critical analysis of the literature with a final discussion of the therapeutic value of the entourage effect with alternate perspectives.

To read the full text of the article, click here ( https://www.tandfonline.com/eprint/ADZX7TA7CAIYUSBUC2RE/full?target=10.1080/17512433.2020.1721281 )

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org.

Visit the IASIC Library here (https://iasic1.org/library/). The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Related Posts

What is THCP?

THCP, which is short for tetrahydrocannabiphorol and scientifically known as (-)-Trans-Δ9-tetrahydrocannabiphorol, is a natural cannabinoid and analog of THC present in varieties of cannabis. It’s thought to be 33 times more active at cannabinoid 1 (CB1) receptors than THC, causing an intense and intoxicating euphoric high. THCP’s legality is stuck between conflicting federal legislation. It’s not

Cannabis Legalization and Detection of Tetrahydrocannabinol (THC) in Injured Drivers

A recent study funded by the Canadian Institutes of Health Research found that after cannabis legalization, the prevalence of moderately injured drivers with a THC level of at least 2 ng per milliliter in participating British Columbia trauma centers more than doubled. The increase was largest among older drivers and male drivers. During the study

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol

For nearly a century, Cannabis has been stigmatized and criminalized across the globe, but in recent years, there has been a growing interest in Cannabis due to the therapeutic potential of phytocannabinoids. With this emerging interest in Cannabis, concerns have arisen about the possible contaminations of hemp with pesticides, heavy metals, microbial pathogens, and carcinogenic compounds during the cultivation, manufacturing,

Scroll to Top